西黄胶囊联合化疗治疗中晚期乳腺癌的疗效观察

Curative Effect of Xihuang Capsules Combined with Chemotherapy on Breast Cancer at Middle- Late Stage

目的:探讨中晚期乳腺癌治疗中联合西黄胶囊及化疗治疗方案的的临床应用价值。方法:以80例中晚期乳腺癌患者作为观察对象,并随机将患者分为接受单纯化疗方案治疗的对照组及接受联合西黄胶囊及化疗治疗方案治疗的观察组,每组40例。对比两组接受治疗2个疗程后的治疗效果、随访生存期、无进展生存期及治疗效果副作用情况。结果:观察组接受2个疗程治疗后的治疗总有效率为82.50%,而对照组接受2个疗程治疗后的治疗总有效率为62.50%,观察组明显高于对照组(P<0.05);同时观察组随访生存期及无进展生存期均明显高于对照组(P<0.05);此外,观察组术后治疗副作用发生率为42.50%,明显低于对照组的65.00%(P<0.05)。结论:联合西黄胶囊及化疗治疗方案可有效的提高中晚期乳腺癌的临床肿瘤效果,并可有效降低治疗副作用的发生率。

Objective： To analyze the efficacy of Xihuang capsules combined with chemotherapy on middle- late stage breast cancer. Methods： 80 cases of middle- late stage breast cancer were observed. Randomly divide the patients into two groups,with pure chemotherapy treatment as the control group and with Xihuang capsules combined with chemotherapy treatment as the observation group,40 cases in each group. Compare the treatment effect,follow- up survival,progression- free survival and side effects of two groups. Results： The total effective rate of observation group was82. 50%,and the total effective rate of control group was 62. 50%. The total effective rate of observation group after 2courses of treatment was significantly higher than that of the control group（ P〈0. 05）. The median survival time and the median progression- free surial time of observation group were longer than those of the control group（ P〈0. 05）. In addition,the side effects of control group was 42. 50%,and the observation group was 65. 00%,and the observation group was obviously less than the control group（ P〈0. 05）. Conclusion： The treatment of Xihuang capsules combined with chemotherapy can effectively improve the effect on middle- late stage breast cancer,and can effectively reduce the incidence of side effects.